Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Disclosing Competing Interests in CDC Guidelines
  • Published Date:
    October, 2015
  • Language:
    English
Filetype[PDF-295.25 KB]


Details:
  • Alternative Title:
    Methods for Developing and Reporting Guidelines: Disclosing Competing Interests in CDC Guidelines
  • Personal Author:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Science
  • Description:
    This document describes CDC’s Office of the Associate Director for Science (OADS) requirements for disclosing the competing interests of authors and members of steering committees and workgroups who develop and report on CDC guidelines and recommendations. A competing interest exists when professional judgment or actions concerning a primary interest (such as patients’ or public’s welfare or the validity of research) may be improperly influenced by a secondary interest such as financial gain, professional advancement, or personal rivalry.1, 2 The commonly used “conflict of interest” term often refers to a narrower understanding of secondary interests such as financial gain. However, the term competing interest is used in this document to indicate a broader meaning of secondary interests, such as nonfinancial personal gain. CDC guidelines and recommendations have the potential to influence practice, policy, and the allocation of resources on a wide scale. Therefore recommendations must be based on objective assessments of the evidence, and values or preferences that influence judgment must be transparent and not prejudiced by secondary interests.

  • Subject:
  • Document Type:
    Pamphlet (or booklet)
  • Place as Subject:
    United States
  • Collection(s):
    Guidelines and Recommendations
  • Main Document Checksum:
  • Supporting Files:
    No Additional Files
    1. Guidelines and Recommendations: A CDC Primer
      Personal Author:
      Carande-Kulis, Vilma
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Science
      Published Date:
      08/13/2012
      Description:
      Guidelines and Recommendations: A CDC Primer was developed by the CDC Guidelines and Recommendations Work Group in 2012, presents an up-to-date overview of key considerations in the development of CDC guidelines. The CDC Primer outlines fundamental p...
      File Type:
      Filetype[PDF - 374.11 KB]
    2. CDC Guideline Development and Reporting Checklist
      Personal Author:
      Carande-Kulis, Vilma
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Science
      Published Date:
      December, 2015
      Description:
      The CDC Guideline Development and Reporting Checklist (GDRC) will help you develop guidelines that comply with well-known standards used by most recognized guideline authorities in the world. The World Health Organization (WHO) defines a guideline as...
      File Type:
      Filetype[PDF - 710.08 KB]
    3. Soliciting External Input when Developing CDC Guidelines and Recommendations
      Personal Author:
      Bosso, Eileen
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Science
      Published Date:
      September 14, 2016
      Description:
      The purpose of this document is to assist CDC staff in determining when and how to solicit external input on guidelines and recommendations.
      File Type:
      Filetype[PDF - 510.56 KB]
    4. CDC Guideline Development Decision Tool
      Corporate Authors:
      Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Science
      Published Date:
      December, 2015
      Description:
      To strengthen the process for developing CDC guidelines, the Office of the Associate Director for Science (OADS), Office of Science Quality (OSQ), Guidelines and Recommendations Activity has developed the CDC Guideline Development Decision Tool (GDDT...
      File Type:
      Filetype[PDF - 474.46 KB]
You May Also Like:
  1. A cross-sectional study of the magnitude, barriers, and outcomes of HIV status disclosure among women participating in a perinatal HIV transmission study, “the Nevirapine Repeat Pregnancy study”
    Personal Author:
    Kiweewa, Flavia M; Bakaki, Paul M; McConnell, Michelle S; Musisi, Maria; Namirembe, Constance; Nakayiwa, Frances; Kusasira, Fiona; Nakintu, Dorothy; Mubiru, Michael C; Musoke, Philippa; Fowler, Mary Glenn;
    Published Date:
    Sep 29 2015
    Source:
    BMC Public Health. 15.
    Description:
    BackgroundHIV status disclosure is a difficult emotional task for HIV-infected persons and may create the opportunity for both social support and rejection. In this study, we evaluated the proportions, patterns, barriers and outcomes of HIV- 1 status...
    File Type:
    Filetype[PDF - 619.24 KB]
  2. National Mesothelioma Virtual Bank: A standard based biospecimen and clinical data resource to enhance translational research
    Personal Author:
    Amin, Waqas; Parwani, Anil V; Schmandt, Linda; Mohanty, Sambit K; Farhat, Ghada; Pople, Andrew K; Winters, Sharon B; Whelan, Nancy B; Schneider, Althea M; Milnes, John T; Valdivieso, Federico A; Feldman, Michael; Pass, Harvey I; Dhir, Rajiv; Melamed, Jonathan; Becich, Michael J;
    Published Date:
    Aug 13 2008
    Source:
    BMC Cancer. 2008; 8:236.
    Description:
    BackgroundAdvances in translational research have led to the need for well characterized biospecimens for research. The National Mesothelioma Virtual Bank is an initiative which collects annotated datasets relevant to human mesothelioma to develop an...
    File Type:
    Filetype[PDF - 886.69 KB]
  3. Impact of inter-partner HIV disclosure patterns in Malawi’s PMTCT program: A mixed-method study
    Personal Author:
    van Lettow, Monique; Cataldo, Fabian; Landes, Megan; Kasende, Florence; Nkhoma, Pearson; van Oosterhout, Joep J.; Kim, Evelyn; Schouten, Erik; Nkhoma, Ernest; Nyirenda, Rose; Tippett Barr, Beth A.;
    Published Date:
    July 26 2019
    Source:
    PLoS One. 14(7)
    Description:
    BackgroundEvidence suggests that disclosure of HIV status between partners may influence prevention of maternal-to-child transmission of HIV (PMTCT) outcomes. We report partner disclosure in relation to maternal antiretroviral therapy (ART) uptake an...
    File Type:
    Filetype[PDF - 468.55 KB]
  4. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008–2010
    Personal Author:
    Webb Mazinyo, Ernesha; Kim, Lindsay; Masuku, Sikhethiwe; Lancaster, Joey L.; Odendaal, Ronel; Uys, Margot; Podewils, Laura Jean; Van der Walt, Martie L.;
    Published Date:
    Jul 21 2016
    Source:
    PLoS One. 11(7).
    Series:
    PEPFAR
    Description:
    BackgroundAdherence to tuberculosis (TB) treatment and antiretroviral therapy (ART) reduces morbidity and mortality among persons co-infected with TB/HIV. We measured adherence and determined factors associated with non-adherence to concurrent TB tre...
    File Type:
    Filetype[PDF - 804.56 KB]
  5. Prevalence and correlates of non-disclosure of maternal HIV status to male partners: a national survey in Kenya
    Personal Author:
    Kinuthia, John; Singa, Benson; McGrath, Christine J.; Odeny, Beryne; Langat, Agnes; Katana, Abraham; Ng’ang’a, Lucy; Pintye, Jillian; John-Stewart, Grace;
    Published Date:
    May 30 2018
    Source:
    BMC Public Health. 18.
    Description:
    BackgroundPrevention of mother-to-child HIV transmission (PMTCT) programs usually test pregnant women for HIV without involving their partners. Non-disclosure of maternal HIV status to male partners may deter utilization of PMTCT interventions since ...
    File Type:
    Filetype[PDF - 607.71 KB]